| Literature DB >> 29401699 |
Marit Skogstad1, Lars-Kristian Lunde2, Bente Ulvestad3, Hans Christian D Aass4, Thomas Clemm5, Asgeir Mamen6, Øivind Skare7.
Abstract
In line with recommendations from both the World Health Organization and the European Union some employers encourage workplace health promotion through physical activity (PA) facilities and leisure time PA-initiatives. The current study describes a 15-month follow-up after an 8-week workplace delivered PA-initiative, investigates if improvements in cardiovascular risk status are sustainable, and elucidates differences according to educational level. One hundred and twenty one employees (43 women) were examined before and after the 8-week PA-initiative and 94 at the 15-month follow-up. PA-levels, blood pressure, resting heart rate, lipids, glycosylated hemoglobin (HbA1c), C-reactive protein (CRP), and selected markers of inflammation were registered at baseline, immediately after the 8-week PA-initiative, and 15 months after baseline. At the end of follow-up (15-month), PA-levels-increased during the 8-week intervention-had returned to baseline values. None of the five improvements in cardiovascular markers (total cholesterol, low density lipoprotein (LDL), P-selectin, CD40Ligand (CD40L) and Monocyte chemoattractant protein-1 (MCP-1)) seen at the 8-week follow-up were sustained. At the 15-month follow-up as compared to baseline HbA1c, CRP (log) and interleukin-6 (IL-6) were reduced by 0.06 mmol/L (95% CI -0.11,-0.01), 0.25 mg/L (95% CI -0.46,-0.04) and 0.39 pg/mL (95% CI -0.75, -0.04), respectively. At baseline, there were differences in cardiovascular risk factors comparing men with low versus high levels of education. No differences in changes in outcomes between these groups of men were found during follow-up. In this study highly educated men generally have lower levels of cardiovascular risk factors, but the effect of PA on such markers in this group do not differ from the effects seen in less educated men.Entities:
Keywords: cardiovascular; occupational health; physical activity
Mesh:
Substances:
Year: 2018 PMID: 29401699 PMCID: PMC5858333 DOI: 10.3390/ijerph15020264
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow diagram for the study.
Characteristics at baseline among females and males participating in the study.
| Outcome | Men | Men | Women |
|---|---|---|---|
| Age (years) | 43.0 (12.9) | 40.8 (11.1) | 42.6 (12.5) |
| BMI (kg/m2) | 27.3 (4.8) | 25.4 (3.0) † | 24.4 (3.1) |
| RHR (bpm) | 65.7 (9.9) | 61.3 (8.5) † | 67.4 (10.9) * |
| Systolic BP (mmHg) | 123.3 (13.2) | 122.3 (11.5) | 112 (16) * |
| Diastolic BP (mmHg) | 78.5 (9.5) | 79.2 (87.8) | 74 (8) * |
| CRP (mg/L) | 2.3 (2.3) | 1.5 (1.7) | 1.9 (1.8) |
| Cholesterol (mmol/L) | 5.0 (1.1) | 5.1 (1.1) | 5.4 (1.1) |
| HDL (mmol/L) | 1.3 (0.3) | 1.4 (0.3) † | 1.9 (0.4) * |
| LDL (mmol/L) | 3.2 (0.9) | 3.3 (1.0) | 3.2 (0.9) |
| HbA1c (mmol/L) | 5.4 (0.4) | 5.2 (0.3) † | 5.2 (0.3) |
| VO2max d (mL/kg min) | 35.8 (5.3) | 40.8 (6.7) | 34.1 (9.5) * |
| IL-6 (pg/mL) | 2.9 (2.1) | 2.1 (1.8) | 2.1 (1.4) |
| MCP-1 (pg/mL) | 317.0 (120.7) | 332.6 (126.3) | 288.3 (89.8) * |
| TNF-α (pg/mL) | 7.5 (4.3) | 5.1 (3.6) † | 3.1 (3.1) * |
| P-selectin (ng/mL) | 50.9 (18.7) | 45.9 (16.8) | 41.0 (10.6) * |
| CD40L (pg/mL) | 4864 (2756) | 3336 (2134) † | 4742 (2590) * |
| Leptin (µg/mL) | 8.7 (7.6) | 5.3 (4.4) † | 16.0 (13.6) * |
| Adiponectin (µg/mL) | 6.6 (3.2) | 7.5 (2.6) | 10.5 (3.8) * |
Significantly different between sex * p < 0.05, a N = 35 for CRP, N = 36 for HbA1c. b N = 42 for BMI and HbA1c, N = 41 for LDL, HDL and cholesterol. c Total number. d N = 12 for men with low education, N = 20 for men with high education, N = 20 for women. e N = 40 for CRP, HDL, LDL and cholesterol, 38 for HbA1c. † Significantly different between the two groups of men.
Figure 2Change in weekly physical activity level; baseline, the 8-week and 15-month follow-up.
Systolic blood pressure, diastolic blood pressure, and resting heart rate.
| Females N = 43 | Males N = 78 | All N = 121 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Unit | Time | β | 95% CI | β | 95% CI | β | 95% CI | ||||||
| Syst. BP | (mmhg) | 15 months vs. BL | −0.81 | −5.88 | 4.27 | 0.752 | 3.92 | 0.42 | 7.42 | 0.029 | 2.27 | −0.59 | 5.13 | 0.119 |
| 15 months vs. 8 weeks | 0.57 | −4.55 | 5.69 | 0.824 | 2.44 | −1.20 | 6.07 | 0.187 | 1.82 | −1.12 | 4.76 | 0.223 | ||
| Diast. BP | (mmhg) | 15 months vs. BL | −0.22 | −3.77 | 3.34 | 0.904 | 2.99 | 0.61 | 5.37 | 0.014 | 1.86 | −0.11 | 3.83 | 0.064 |
| 15 months vs. 8 weeks | −0.56 | −4.15 | 3.03 | 0.756 | 0.59 | −1.89 | 3.06 | 0.640 | 0.19 | −1.83 | 2.21 | 0.851 | ||
| RHR | (bmp) | 15 months vs. BL | 4.03 | 0.49 | 7.58 | 0.026 | 0.17 | −2.64 | 2.99 | 0.903 | 1.18 | −1.07 | 3.43 | 0.303 |
| 15 months vs. 8 weeks | 5.04 | 1.47 | 8.62 | 0.006 | −1.24 | −4.16 | 1.68 | 0.402 | 0.70 | −1.61 | 3.01 | 0.553 | ||
Figure 3Changes in HbA1c, lipids, CRP, Blood pressure, RHR and selected biomarkers according to time; baseline, 8-week follow-up and 15-month follow-up. Plots are based on participants observed at all three time points.
Cholesterol, LDL, HDL, and HbA1c.
| Females N = 42 | Males N = 77 | All N = 119 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Unit | Time | β | 95% CI | β | 95% CI | β | 95% CI | ||||||
| Cholest. | (mmol/L) | 15 months vs. BL | −0.04 | −0.31 | 0.22 | 0.741 | 0.11 | −0.08 | 0.31 | 0.256 | 0.05 | −0.10 | 0.21 | 0.500 |
| 15 months vs. 8 weeks | 0.25 | −0.02 | 0.52 | 0.072 | 0.11 | −0.09 | 0.32 | 0.270 | 0.17 | 0.01 | 0.33 | 0.043 | ||
| LDL | (mmol/L) | 15 months vs. BL | −0.05 | −0.24 | 0.15 | 0.645 | 0.10 | −0.06 | 0.27 | 0.226 | 0.05 | −0.08 | 0.18 | 0.440 |
| 15 months vs. 8 weeks | 0.23 | 0.03 | 0.43 | 0.024 | 0.14 | −0.03 | 0.32 | 0.114 | 0.18 | 0.05 | 0.31 | 0.009 | ||
| HDL | (mmol/L) | 15 months vs. BL | 0.01 | −0.09 | 0.11 | 0.856 | −0.04 | −0.09 | 0.01 | 0.151 | −0.02 | −0.07 | 0.02 | 0.330 |
| 15 months vs. 8 weeks | 0.06 | −0.04 | 0.15 | 0.266 | −0.04 | −0.09 | 0.01 | 0.134 | −0.01 | −0.06 | 0.04 | 0.750 | ||
| HbA1c | (mmol/L) | 15 months vs. BL | −0.05 | −0.14 | 0.04 | 0.301 | −0.06 | −0.11 | −0.01 | 0.028 | −0.06 | −0.11 | −0.01 | 0.014 |
| 15 months vs. 8 weeks | −0.02 | −0.12 | 0.07 | 0.617 | −0.05 | −0.10 | 0.01 | 0.080 | −0.04 | −0.09 | 0.01 | 0.088 | ||
CRP, IL-6, MCP-1 and TNF-α.
| Females N = 42 | Males N = 77 a | All N = 119 b | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Unit | Time | β | 95% CI | β | 95% CI | β | 95% CI | ||||||
| logCRP | (mg/L) | 15 months vs. BL | −0.18 | −0.56 | 0.19 | 0.338 | −0.28 | −0.53 | −0.03 | 0.030 | −0.25 | −0.46 | −0.04 | 0.019 |
| 15 months vs. 8 weeks | −0.06 | −0.44 | 0.32 | 0.737 | −0.16 | −0.42 | 0.10 | 0.234 | −0.13 | −0.34 | 0.08 | 0.232 | ||
| IL-6 | (pg/mL) | 15 months vs. BL | 0.00 | −0.51 | 0.52 | 0.994 | −0.62 | −1.1 | −0.13 | 0.013 | −0.39 | −0.75 | −0.04 | 0.032 |
| 15 months vs. 8 weeks | 0.14 | −0.34 | 0.62 | 0.572 | −0.34 | −0.8 | 0.12 | 0.154 | −0.18 | −0.51 | 0.16 | 0.310 | ||
| MCP-1 | (pg/mL) | 15 months vs. BL | 41.36 | 7.10 | 75.61 | 0.020 | 6.82 | −24.40 | 38.04 | 0.669 | 18.63 | −5.23 | 42.50 | 0.127 |
| 15 months vs. 8 weeks | 20.75 | −11.69 | 53.20 | 0.212 | 19.31 | −10.86 | 49.48 | 0.211 | 18.80 | −4.02 | 41.61 | 0.107 | ||
| TNF-α | (pg/mL) | 15 months vs. BL | 0.17 | −0.94 | 1.28 | 0.761 | −0.31 | −1.27 | 0.65 | 0.523 | −0.15 | −0.93 | 0.62 | 0.697 |
| 15 months vs. 8 weeks | −0.06 | −1.11 | 0.99 | 0.907 | 0.01 | −0.91 | 0.93 | 0.983 | −0.06 | −0.80 | 0.68 | 0.877 | ||
a N = 75 for CRP, IL-6, TNF-α. b N = 117 for CRP, IL-6, TNF-α.
P-selectin, CD40L, leptin, and adiponectin.
| Females N = 42 | Males N = 77 | All N = 119 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Unit | Time | β | 95% CI | β | 95% CI | Β | 95% CI | ||||||
| P-selec. | (ng/mL) | 15 months vs. BL | 1.55 | −2.94 | 6.04 | 0.501 | 1.71 | −2.41 | 5.83 | 0.417 | 1.75 | −1.31 | 4.82 | 0.263 |
| 15 months vs. 8 weeks | 2.73 | −1.53 | 6.98 | 0.211 | 3.30 | −0.67 | 7.28 | 0.105 | 3.06 | 0.13 | 6.00 | 0.041 | ||
| CD40L | (pg/mL) | 15 months vs. BL | 267.82 | −903.72 | 1439.35 | 0.655 | 1149.37 | 316.46 | 1982.28 | 0.007 | 851.70 | 169.57 | 1533.83 | 0.015 |
| 15 months vs. 8 weeks | 803.57 | −299.04 | 1906.19 | 0.155 | 1418.38 | 611.60 | 2225.16 | 0.001 | 1204.99 | 551.66 | 1858.32 | 0.000 | ||
| Leptin ln | (µg/mL) | 15 months vs. BL | 0.10 | −0.17 | 0.37 | 0.482 | 0.08 | −0.11 | 0.28 | 0.408 | 0.09 | −0.08 | 0.25 | 0.311 |
| 15 months vs. 8 weeks | 0.04 | −0.22 | 0.31 | 0.744 | 0.10 | −0.09 | 0.29 | 0.308 | 0.07 | −0.09 | 0.23 | 0.369 | ||
| Adipon. | (µg/mL) | 15 months vs. BL | −0.45 | −1.34 | 0.44 | 0.324 | −0.01 | −0.67 | 0.66 | 0.985 | −0.20 | −0.73 | 0.33 | 0.457 |
| 15 months vs. 8 weeks | −0.49 | −1.33 | 0.35 | 0.252 | −0.11 | −0.75 | 0.53 | 0.727 | −0.28 | −0.78 | 0.23 | 0.283 | ||